- These are not official programs of the American College of Rheumatology.
- All industry sessions will be available on-demand on the virtual meeting platform until March 10, 2022.
UCB Program: Expert Perspectives on a New Treatment
Exhibit Hall, Innovation Theater A
Developed and offered by UCB (Non-CME)
NeuroImmune Modulation for Rheumatoid Arthritis
Exhibit Hall, Booth #3257
Developed and offered by SetPoint Medical (Non-CME)
Exploring the Clinical Profile of SAPHNELO® (anifrolumab-fnia): An Expert Review of the TULIP Pivotal Trials and 4-Year Long-Term Extension Study
Exhibit Hall, Innovation Theater B
Developed and offered by AstraZeneca (Non-CME)
The Importance of Preventing Kidney Flares in Lupus Nephritis
Exhibit Hall, Booth #3257
Developed and offered by GSK (Non-CME)
Reframing Lupus Nephritis Management
Exhibit Hall, Booth #3257
Developed and offered by GSK (Non-CME)
A Collaborative Approach to Clinical Practice Guidelines for Sjögren’s Disease
Exhibit Hall, Booth #3257
Developed and offered by Sjögren’s Foundation (Non-CME)
Sometimes the Culprit is Right in Front of You: Hypophosphatasia
Exhibit Hall, Booth #3257
Developed and offered by Alexion (Non-CME)
Moving Real World Research FORWARD
Exhibit Hall, Booth #3257
Developed and offered by National Databank for Rheumatic Diseases (Non-CME)
Mystery Diagnosis: Recognizing X-linked Hypophosphatemia (XLH)
Exhibit Hall, Booth #3257
Developed and offered by Kyowa Kirin (Non-CME)
Mystery Diagnosis: Recognizing XLH (Continued)
Exhibit Hall, Booth #3257
Developed and offered by Kyowa Kirin (Non-CME)
Q&A/Continue the Conversation
Exhibit Hall, Booth #3257
(Non-CME)
Tremfya in Focus: Multi-Specialty Insights From a Rheumatologist, Dermatologist, and Gastroenterologist
Exhibit Hall, Innovation Theater B
Developed and offered by Johnson & Johnson (Non-CME)
Weighing the Evidence: Obesity and Inflammation in PsA
Marriott Marquis, Room Catholic University/University of DC
Developed and offered by Eli Lilly and Company (Non-CME)
Updating the Treatment Landscape of SLE for Earlier Introduction of Biologics
Marriott Marquis, Room Shaw/LeDroit Park
Developed and offered by GSK (Non-CME)
Achieving Your Treatment Goals: Consider When a Treatment Switch in RA May Be the Right Transition For Your Patients
Exhibit Hall, Innovation Theater A
Developed and offered by AbbVie (Non-CME)
Patient Perspectives on Rheumatoid Arthritis Treatment Options
Exhibit Hall, Booth #3257
Developed and offered by SetPoint Medical (Non-CME)
A Dual Product Event: Ixekizumab and Tirzepatide
Exhibit Hall, Innovation Theater B
Developed and offered by Eli Lilly and Company (Non-CME)
Organ Damage in SLE: More Than Just the Kidneys
Exhibit Hall, Booth #3257
Developed and offered by GSK (Non-CME)
Early Initiation of Biologics and Organ Damage
Exhibit Hall, Booth #3257
Developed and offered by GSK (Non-CME)
The Clinical Relevance of Anti-DFS70 Autoantibodies
Exhibit Hall, Booth #3257
Developed and offered by Labcorp (Non-CME)
What You Need to Know about Sarcoidosis
Exhibit Hall, Booth #3257
Developed and offered by the Foundation for Sarcoidosis Research (Non-CME)
A Call for Early SLE Intervention in Minoritizied Patients
Exhibit Hall, Booth #3257
Developed and offered by GSK (Non-CME)
Q&A/Continue the Conversation
Exhibit Hall, Booth #3257
(Non-CME)
Collaborative Frameworks in CAR T-Cell Therapy for Autoimmune Diseases
Exhibit Hall, Innovation Theater A
Developed and offered by Bristol Myers Squibb (Non-CME)
Real-World Solutions: The Role of Novel Biomarkers in Diagnosing SLE and RA
Exhibit Hall, Innovation Theater B
Developed and offered by Exagen (Non-CME)
Changing the Treatment Paradigm in Recurrent Pericarditis (RP): Moving Beyond an Episodic Approach
Exhibit Hall, Innovation Theater A
Developed and offered by Kiniksa Pharmaceuticals (Non-CME)
Expert Perspectives on Dual Inhibition of IL-17A + IL-17F: A Different Mechanism of Action
Exhibit Hall, Innovation Theater B
Developed and offered by UCB (Non-CME)
What We Know About This Oral Medication in Moderate-to-Severe Plaque Psoriasis and Its 4-Year Data
Marriott Marquis, Room Capitol/Congress
Developed and offered by Bristol Myers Squibb (Non-CME)
Does Control of Inflammation Matter? Striving for Better Patient Outcomes in PsA and axSpA
Marriott Marquis, Room Liberty I/J/K/L
Developed and offered by UCB (Non-CME)
Advances in Systemic Lupus Erythematosus (SLE) Management: An Expert Discussion on Treat-to-Target Approaches and a Clinical Data Review of a Novel Treatment Option
Marriott Marquis, Room Independence E/F/G/H
Developed and offered by AstraZeneca (Non-CME)
Unraveling IL-23, the Common Thread Across Psoriasis, Psoriatic Arthritis, and Ulcerative Colitis
Marriott Marquis, Room Catholic University/University of DC
Developed and offered by Johnson & Johnson (Non-CME)
Achieving an Immune System RESET: The Next Act in CAR T Therapy
Exhibit Hall, Innovation Theater A
Developed and offered by Cabaletta Bio (Non-CME)
Three Rheumatologic Diseases, One FDA-Approved Option to Consider for Appropriate Patients, From Juveniles to Adults
Exhibit Hall, Innovation Theater B
Developed and offered by Sanofi Pharmaceuticals (Non-CME)
Beyond the Basics: What Makes Immunoglobulin Therapy Effective in Dermatomyositis?
Exhibit Hall, Innovation Theater A
Developed and offered by Octapharma (Non-CME)
Expert Perspectives: Identification and Management of Eosinophilic Granulomatosis with Polyangiitis
Exhibit Hall, Innovation Theater B
Developed and offered by GSK
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
Marriott Marquis, Room Catholic University/University of DC
Developed and offered by Physicians’ Education Resource (CME) and supported by Amgen
Defining a Path to Remission in Systemic Lupus Erythematosus (SLE)
Marriott Marquis, Room Independence E/F/G/H
Developed and offered by AstraZeneca (Non-CME)
Investigating CAR T-Cell Therapy for Autoimmune Diseases: Past, Present and Future
Marriott Marquis, Room Independence A/B/C/D
Developed and offered by Bristol Myers Squibb (Non-CME)
Targeting Eosinophilic Inflammation in EGPA
Marriott Marquis, Room Shaw/LeDroit Park
Developed and offered by AstraZeneca (Non-CME)
Unmasking IgG4‐Related Disease: Creating Awareness and Improving Diagnosis, Treatment, and Patient Quality of Life
Westin Washington DC Downtown, Room Rock Creek B/C
Developed and offered by Vindico Medical Education and supported by Amgen (CME)
KYV-101 Anti-CD19 CAR T-Cell Therapy: The Future of Autoimmune Disease Treatment
Grand Hyatt Washington, Room Constitution B/C/D/E & Corridors B/C
Developed and offered by Kyverna Therapeutics (Non-CME)
Are Rheumatologists Diagnosing and Managing Progressive Fibrosing Interstitial Lung Diseases Effectively?
Marriott Marquis, Room Independence A/B/C/D
Independent medical education grant support for this session is provided by Boehringer Ingelheim Pharmaceuticals, Inc., and sponsored by Med Learning Group (CME)
Educational Symposium on Axial Spondyloarthritis and Psoriatic Arthritis
Marriott Marquis Washington, DC Independence Salons E/F/G/H
Developed and offered by SPARTAN, GRAPPA, and ASAS, and supported by an educational grant from UCB
Understanding Early Advanced Therapy Use in Lupus: A Treatment Evolution
Exhibit Hall, Innovation Theater A
Developed and offered by GSK (Non-CME)
Conversations in Autoimmune-Associated Interstitial Lung Disease (ILD): The Patient Journey, The Physician Perspective
Exhibit Hall, Innovation Theater B
Independent medical education grant support for this session is provided by Boehringer Ingelheim Pharmaceuticals, Inc., and sponsored by Med Learning Group (Non-CME)